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ABSTRACT
Background: A lack of information on the etiology of anemia has
hampered the design and monitoring of anemia-control efforts.
Objective: We aimed to evaluate predictors of anemia in preschool
children (PSC) (age range: 6–59 mo) by country and infection-
burden category.
Design: Cross-sectional data from 16 surveys (n = 29,293) from the
Biomarkers Reflecting Inflammation and Nutritional Determinants
of Anemia (BRINDA) project were analyzed separately and pooled
by category of infection burden. We assessed relations between
anemia (hemoglobin concentration ,110 g/L) and severe anemia
(hemoglobin concentration ,70 g/L) and individual-level (age, an-
thropometric measures, micronutrient deficiencies, malaria, and in-
flammation) and household-level predictors; we also examined the
proportion of anemia with concomitant iron deficiency (defined as
an inflammation-adjusted ferritin concentration ,12 mg/L). Coun-
tries were grouped into 4 categories on the basis of risk and burden
of infectious disease, and a pooled multivariable logistic regression
analysis was conducted for each group.
Results: Iron deficiency, malaria, breastfeeding, stunting, underweight,
inflammation, low socioeconomic status, and poor sanitation were each
associated with anemia in .50% of surveys. Associations between
breastfeeding and anemia were attenuated by controlling for child
age, which was negatively associated with anemia. The most consistent
predictors of severe anemia were malaria, poor sanitation, and under-
weight. In multivariable pooled models, child age, iron deficiency,
and stunting independently predicted anemia and severe anemia.
Inflammation was generally associated with anemia in the high- and
very high–infection groups but not in the low- and medium-infection
groups. In PSC with anemia, 50%, 30%, 55%, and 58% of children
had concomitant iron deficiency in low-, medium-, high-, and very
high–infection categories, respectively.
Conclusions: Although causal inference is limited by cross-sectional
survey data, results suggest anemia-control programs should address
both iron deficiency and infections. The relative importance of
factors that are associated with anemia varies by setting, and thus,
country-specific data are needed to guide programs. Am J Clin Nutr
2017;106(Suppl):402S–15S.
Keywords: anemia, children, inflammation, iron, survey
INTRODUCTION
Preschool children (PSC) continue to have the highest bur-
den of anemia compared with that of other population groups
(estimated prevalence of 43% globally in 2011 and #71% in
Central and West Africa) with only a 4-percentage point (pp)
reduction from 1995 to 2011 (1). Furthermore, 2% of children
globally (4.9% in Central and West Africa) were estimated to
have severe anemia (1), which is associated with increased mor-
tality (2). In a recent meta-analysis of data from African children,
each 10-g/L increase in hemoglobin concentration was associ-
ated with a 24% mortality reduction (3). Iron-deficiency anemia
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(IDA) is associated with poorer cognitive and neurologic function
with predicted long-term health and economic consequences (4)
and is a major contributor to the estimated years lived with a
disability in children and adolescents (5).
The etiology of anemia is complex and context-dependent and
likely differs between mild and severe anemia (6). Various con-
ceptual models have been developed to illustrate the pathways
between proximal and distal determinants of anemia (4) including a
framework that is specific to the Biomarkers Reflecting Inflam-
mation and Nutritional Determinants of Anemia (BRINDA) project
(7). Many potential causes of anemia are biologically interrelated,
such as infections and nutritional status, and may also be driven
by the same environmental and household characteristics, such
as low socioeconomic status (SES), sanitation, and education (4).
However, population-level assessments, particularly in low-
resource settings, have frequently failed to adequately assess
the etiology of anemia. Instead, risk factors for anemia have been
inferred from limited indicators that are available from Demo-
graphic and Health Surveys or from small, nonrepresentative
studies (8). This lack of information on the setting-specific risk
factors for anemia is a major challenge to the development and
evaluation of effective anemia-control programs and can result in
an inefficient allocation of scarce public health resources.
Iron deficiency (ID) has been identified as an important cause
of anemia for decades (9). As such, prevention and treatment
strategies for populations at risk of anemia typically consist of
approaches to improve iron status (10, 11). As these programs are
scaled up, concerns have been raised about the potential adverse
effects of providing additional iron to children, particularly to
children who are iron replete, in settings with heavy burdens of
infectious disease (12, 13).
In the absence of individual data on iron status, the prevalence of
IDA (typically defined as having both ID and anemia) has been
estimated by assuming that 50% of anemia is attributable to ID and,
despite the rough nature of this estimate (14), the value has been
widely referenced. Although the 50% estimate has been supported by
some studies (8, 15), other studies have suggested that the proportion
of anemia that is associated with IDmay differ substantially in certain
settings and subgroups (6, 16). In addition, estimates of the prevalence
of ID and IDA depend on the indicator of iron status that is used and
whether iron biomarkers are adjusted for inflammation (17–20).
The objective of this articlewas to assess the associations between
anemia and posited risk factors for anemia in PSC in a variety of
settings through a secondary analysis of a database of 16 population-
based surveys that have been assembled under the BRINDA project
(7, 21). We addressed the following research questions: 1) What
are the individual- and household-level factors that are associated
with anemia and severe anemia in PSC, and how do these vary
across settings with different burdens of infectious disease? 2)
What proportion of anemia is associated with ID, and how is the
relation between anemia and ID affected by the application of new
methods to adjust iron-status indicators for inflammation? and 3)
What is the relative strength of the association between anemia
and factors that are independently associated with anemia?
METHODS
We used data from the BRINDA project (www.BRINDA-
nutrition.org); details of the project objectives and approach have
previously been published (21). The BRINDA protocol was
reviewed by the institutional review boards of NIH and was
deemed to be non–human subjects research. Descriptions of the
original surveys and BRINDA selection criteria are included
in the methodologic summary in this issue (7). All 16 surveys
(representing 14 countries) with PSC (age range: 6–59 mo) from
the BRINDA project included measures of hemoglobin and in-
flammation [C-reactive protein (CRP) or a-1-acid glycoprotein
(AGP)] and, thus, were eligible for the current analysis. How-
ever, we excluded Papua New Guinea from analyses that were
related to iron status because only soluble transferrin receptor,
and not ferritin, was measured.
Laboratory analysis
Hemoglobin concentrations were measured at the time of
blood collection with the use of a portable hemoglobinometer
(HemoCue; all surveys except the United States) or after blood
collection with a Beckman Coulter MAXM hematology flow
cytometer (Beckman Coulter Inc.; United States only). Venous or
capillary blood was collected from each respondent, and plasma
or serum was stored at 2208C until analysis; one survey used
dried blood spots. Ferritin, retinol-binding protein (RBP), CRP,
and AGP concentrations were assessed with the use of a sand-
wich ELISA at the VitMin Laboratory in 9 of 16 PSC surveys
(22). CRP was measured with the use of in-country methods in
Colombia and Georgia (turbidimetry), Mexico (nephelometry),
and the United States (immunoassay), and AGP was measured
with the use of in-country methods in Nicaragua (turbidimetry)
and Pakistan (immunoassay). Serum retinol was measured by HPLC
in 5 surveys (Colombia, Nicaragua, Mexico 2006 and 2011, and
Pakistan). Malaria was assessed with the use of microscopy in
Kenya (2007 and 2010) and Coˆte d’Ivoire (23), the Paracheck Pf
rapid diagnostic test (Orchid Biomedical System) in Liberia (24),
and plasma histidine-rich protein 2 (Cellabs Pty Ltd.) in Cameroon
(25). The methods for identifying data sets, inclusion and exclusion
criteria, and data management for the BRINDA project have been
described in the methodologic overview in this supplement, which
is an open access publication (7).
Categorization of countries by infection burden
Certain infectious diseases, such as malaria, contribute to
anemia, but the burden of these diseases is not distributed evenly
across countries. To understand how factors that are associated
with anemia may differ for settings with varying burdens of in-
fectious disease, we categorized countries into groups reflecting
risk and burden of infectious disease on the basis of an exami-
nation of country-level characteristics, which is an approach that
was adapted from Petry et al. (26). Specifically, each country was
assigned scores that reflected sanitation, drinking water quality,
and prevalences of malaria, diarrhea, and schistosomiasis (Sup-
plemental Table 1). The scores were summed for each country
and were used to divide countries into categories reflecting low,
moderate, high, and very high burdens of infection. With the use
of this approach, countries were grouped as follows: 1) very high
infection burden: Cameroon, Coˆte d’Ivoire, Kenya (2007 and
2010), and Liberia; 2) high infection burden: Bangladesh, Laos,
Papua New Guinea, and the Philippines; 3) moderate infection
burden: Colombia, Mexico (2006 and 2012), and Nicaragua; and
4) low infection burden: Georgia and the United States.
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Although alternate systems of defining the burden of infectious
disease are possible, we adopted this system as a reasonable
approach because of the following advantages: 1) the categories
were roughly consistent with geographic regions, which facilitated
interpretation, and 2) the 5 African data sets each represented a
setting with a severe burden of malaria morbidity, and only these
5 data sets included individual-level information on malaria in-
fection. The categories were also generally consistent with the
prevalence of elevated CRP and AGP concentrations, although the
categories were based on risk or burden of infection and not in-
flammation specifically.
Definitions of outcomes and covariates
The primary outcomes were hemoglobin concentration (in
grams per liter), anemia (defined as a hemoglobin concentration
,110 g/L), and severe anemia (defined as a hemoglobin con-
centration ,70 g/L) (27). Hemoglobin concentrations were ad-
justed for altitude when this information was available (n = 6
surveys) (27, 28). We applied the following categories to in-
terpret the prevalence of anemia with regard to the public health
burden—severe:.40%; moderate: 20.0–39.9%; mild: 5.0–19.9%;
and normal: #4.9% (29).
A conceptual framework outlining the expected relations
between anemia and selected potential risk factors for anemia,
which is summarized in the introductory methods paper in this
series (7), was used to guide the selection of covariates. De-
mographic characteristics included child age (expressed as a
continuous variable, in months) and sex. Household SES was
defined within each survey on the basis of household income in
Papua New Guinea, the poverty-index ratio in the United States,
and an asset score in all other surveys (except in Georgia, where
income or assets were not measured). SES scores were dichot-
omized for bivariate analyses. Other household characteristics
were as follows—location (urban or rural); sanitation conditions:
improved or poor, comprising unimproved and open defecation
(30); water source [improved or unimproved (30)]; and educa-
tional level of the head of household and/or the child’s mother
(no education or primary education compared with secondary
education or university). Child breastfeeding status was recorded
as currently breastfeeding or breastfed in the past 24 h. Indicators
of infection and inflammation included plasma or serum CRP
and/or AGP (with inflammation defined as a CRP concentration
.5 mg/L and/or AGP concentration .1 g/L, depending on the
indicators available), and current or recent malaria (a positive
diagnosis as assessed according to the laboratory methods pre-
viously described). Indicators of child nutritional status were as
follows: stunting (height-for-age z score ,22 SDs), wasting
(weight-for-height z score,22 SDs), and underweight (weight-
for-age z score ,22 SDs), which were calculated with the use
of the WHO growth standards (31); ID [inflammation-adjusted
ferritin concentration ,12 mg/L (32, 33)]; and vitamin A de-
ficiency (VAD) [inflammation-adjusted RBP or retinol concen-
tration ,0.70 mmol/L (34)].
To reduce confounding between indicators of ID and VAD
with indicators of inflammation, regression-adjusted ferritin (33)
and RBP or retinol concentrations were used to estimate in-
dividual iron and vitamin A status, respectively. Specifically,
concentrations of each biomarker were adjusted for the presence
of inflammation with the use of regression coefficients that were
derived from linear regression models with the micronutrient
biomarker as the outcome and CRP and/or AGP as continuous
predictor variables; methods are described in detail in this issue
(32, 34) and illustrated in Supplemental Figure 1. The adjustment
method that was retained for this analysis used country-specific
regression coefficients (internal regression coefficients) and refer-
ence CRP and AGP values of 22.26 ln(mg/L) and 20.52 ln(g/L),
respectively. Other variables that were available for a small number
of surveys and, thus, were not included in the current analyses were
hemoglobinopathies, intestinal helminths, plasma or serum vitamin
B-12, plasma or red blood cell folate, and plasma zinc.
Statistical analyses
Descriptive analyses were conducted with SAS version 9.4
software (SAS Institute). The Taylor linearization method was
used to obtain unbiased estimates that incorporated the sampling
weight, strata, and cluster (as applicable). Sampling weights for
each data set were provided by survey representatives. For pooled
analyses, population-based weights were rescaled so that the sum
of the weights within each study was proportional to the size of
the population represented by the data set (e.g., all children within
the selected age group in a country or region).
Associations between the primary outcomes (anemia and severe
anemia) and each potential predictor were tested separately for each
survey with the Rao-Scott chi-square test (except for age, which
was examined as a continuous predictor variable with the use of a
survey logistic regression procedure with Wald’s chi-square test).
Pooled analyses were also conducted for each of the 4 infection
groups. For bivariate analyses, prevalence ratios were estimated
for each survey and infection group. Predictors of severe anemia
were not examined in the countries in the low and medium in-
fection burden groups because of the small number of cases.
We examined the relation between anemia and ID with and
without adjustment of ferritin concentrations for inflammation
with the use of the new, to our knowledge, regression-basedmethod
proposed by Namaste et al. (7), as previously noted. We calculated
IDA as the proportion of all children with both anemia and ID. In
addition, we calculated the proportion of anemic individuals with
ID (IDA:all anemia; for comparison with the 50% estimate) and the
prevalence of anemia in individuals with and without ID.
As an exploratory analysis, we developed amultivariable logistic
regression model to identify independent predictors of anemia.
Separate models were constructed for each of the 4 infection groups
and for all anemia and severe anemia. The model development
followed a block stepwise approach. Covariates were introduced
into the model in blocks in the order of anticipated proximity in the
causal pathway as follows: 1) individual characteristics and proximal
anemia determinants [age (continuous, in months), sex, ID, inflam-
mation; and current or recent malaria (only countries with high
infection burden)]; 2) other variables related to nutritional status
(breastfeeding, VAD, stunting, and wasting); 3) household water and
sanitation; and 4) household demographics (rural or urban location,
education of the head of the household or caregiver, and household
SES). Within each geographic grouping, we limited the list of co-
variates to those available for all countries in that group with the
exception of Papua New Guinea as previously noted.
The model construction proceeded as follows. Individual char-
acteristics and proximal anemia determinants (group 1 variables, as
described previously) as well as an indicator variable for the
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survey were forced into the model. Two-factor interactions of
each predictor variable with age were introduced. Interactions
with P . 0.10 were removed from the model in a stepwise
manner. The second group of variables (group 2: other nutri-
tional status variables) along with 2-factor interactions between
each variable and age were introduced into the model. Non-
significant variables (P-interactions. 0.10, P-main effects. 0.05)
were removed in a stepwise manner, beginning with inter-
actions (and retaining any main effects for which an interaction
was significant). The same process was repeated for the third
and fourth groups of variables. The final model was reviewed, and
any nonsignificant terms were removed (except main effects for
group 1 variables). Interactions of covariates with child age were
described by examining the ORs for the covariate at different values
for child age (12 and 48 mo). To assess heterogeneity by country
in relations between anemia and each covariate, we constructed
separate logistic regression models to examine the interaction
(cross-product) between the survey indicator variable and each
covariate of interest.
RESULTS
Population characteristics
Our study samplewas restricted to participants with nomissing
values for hemoglobin and included a total of 29,293 PSC
observations. Participants who were excluded because of missing
hemoglobin values (n = 473; 1.6% of observations) did not differ
from those who were included with regard to sex or SES except
that children without hemoglobin measurements in the Mexico
2012 survey were more likely to have low SES than were children
with hemoglobin measurements (data not shown). In addition,
children without hemoglobin measurements were older in 6 surveys
and younger in 5 surveys than were the children with hemoglobin
measurements. All children were within the range of 6–59 mo of
age, but the age range of participants differed by survey from 6–
11 mo in Bangladesh to 12–59 mo in other surveys (Table 1). In
pooled analyses, the mean child age was lower, and the proportion
of children who were currently breastfeeding was greater in very
high– and high-infection groups than in moderate- and low-infection
groups (24.7 and 22.8 compared with 39.8 and 36.6 mo, respec-
tively; 50.4% and 58.0% compared with 18.9% and 10.3%,
respectively).
Anemia prevalence in PSC ranged from 2.1% in the United
States to 83.5% in Bangladesh with weighted prevalence esti-
mates of 2.4%, 18.0%, 56.9%, and 68.1% for low-, moderate-,
high-, and very high–infection groups, respectively. Severe
anemia affected 2.1–8.1% of PSC in the very high–infection
group and 0.5–4.4% of PSC in surveys in the high-infection
group but few PSC in the moderate- and low-infection groups.
Anemia was characterized as a severe public health problem
(.40%) in all surveys in the high- and very high–infection
TABLE 1
Age, breastfeeding status, and anemia prevalence in preschool children by country and category of infection burden: the
BRINDA project1
n Age,2 mo Breastfeeding, % Anemia, % Severe anemia, %
Country
Bangladesh 1491 8.3 (6.0–11.9) NA 83.5 (81.1, 85.9) 1.1 (0.6, 1.6)
Cameroon 762 31.0 (12.0–59.9) 16.2 (13.0, 19.3) 54.3 (49.4, 59.3) 2.8 (1.4, 4.1)
Colombia 3864 37.6 (12.0–59.9) NA 13.2 (11.7, 14.6) 0.1 (0, 0.3)
Coˆte d’Ivoire 742 31.6 (6.0–59) NA 71.2 (66.4, 76.0) 7.3 (5.2, 9.4)
Georgia 2136 36.4 (12.0–60.0) 10.3 (8.5, 12.1) 23.0 (19.7, 26.3) 0.6 (0.1, 1.1)
Kenya 2007 873 20.0 (6.0–35.9) 56.3 (51.8, 60.7) 66.9 (63.0, 70.8) 3.2 (2.0, 4.4)
Kenya 2010 843 21.5 (6.0–35.9) 54.0 (50.0, 58.0) 71.5 (67.9, 75.1) 8.1 (6.1, 10.1)
Laos 479 33.1 (6.0–59.9) 31.5 (26.0, 36.9) 40.7 (31.2, 50.1) 0.5 (0, 1.2)
Liberia 1433 19.9 (6.0–35.9) 49.5 (46.3, 52.7) 59.5 (55.6, 63.4) 0.8 (0.3, 1.4)
Mexico 2006 1592 41.6 (12.0–59.9) NA 20.7 (17.5, 23.8) 0.1 (0, 0.2)
Mexico 2012 2228 39.2 (12.0–59.9) 16.0 (12.8, 19.2) 16.8 (14.7, 19.0) 0.1 (0, 0.3)
Nicaragua 1423 33.4 (6.0–59.9) 60.9 (53.2, 68.6) 20.2 (15.7, 24.7) 0.2 (0, 0.5)
Pakistan 7477 27.3 (6.0–59.9) 76.0 (74.0, 78.0) 63.1 (61.8, 64.5) 4.4 (3.8, 5.0)
Papua New Guinea 871 31.4 (6.0–59.9) 42.6 (38.9, 46.3) 48.0 (42.3, 53.7) 2.4 (1.0, 3.7)
Philippines 1767 15.0 (6.0–23.9) 49.0 (45.6, 52.4) 41.9 (37.8, 45.9) 0.3 (0, 0.7)
United States 1312 36.6 (12.0–59.9) NA 2.1 (1.0, 3.3) 0.0
Infection burden
Low 3448 36.6 (12.0–59.9) 10.3 (8.5, 12.1) 2.4 (1.3, 3.5) 0 (0, 0)
Moderate 9107 39.8 (6.0–59.9) 18.9 (15.8, 21.9) 18.0 (16.4, 19.6) 0.1 (0, 0.2)
High 12,085 22.8 (6.0–59.9) 58.0 (56.0, 60.1) 56.9 (55.4, 58.3) 2.8 (2.4, 3.2)
Very high 4653 24.7 (6.0–59.9) 50.4 (47.9, 52.9) 68.1 (66.0, 70.1) 5.7 (4.8, 6.6)
1 All values are proportions (95% CIs), unless otherwise specified. Breastfeeding was reported as current breastfeeding
or breastfeeding in the past 24 h. Anemia was defined as a hemoglobin concentration,110 g/L. Severe anemia was defined
as a hemoglobin concentration,70 g/L. Countries were grouped as follows—low infection burden: Georgia and the United
States; moderate infection burden: Colombia, Mexico (2006 and 2012), and Nicaragua; high infection burden: Bangladesh,
Laos, Pakistan, Papua New Guinea, and the Philippines; and very high infection burden: Cameroon, Coˆte d’Ivoire, Kenya
(2007 and 2010), and Liberia. BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia;
NA, not available.
2 All values are means (minimums to maximums).
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groups and as a mild (5.0–19.9%) or moderate (20.0–39.9%)
public health problem in all other countries except the United
States where the anemia prevalence was considered to be normal
(#4.9%).
Consistent with the infection-burden groupings, the preva-
lences of both ID and inflammation were lowest in the low-
infection group (13.1% and 6.2%, respectively) and greatest in
the group with a very high infection burden (54.4% and 63.0%,
respectively) (Table 2). VAD prevalence appeared highest in the
group with a high infection burden, but this was driven by the
high prevalence of VAD in Pakistan (54.5%).
Bivariate associations with anemia and severe anemia
The factors that were associated with anemia differed by
survey, but some patterns were apparent (Tables 3, 4). Child age
was positively associated (P , 0.05) with hemoglobin concen-
trations in all surveys except in Bangladesh, Liberia, and Kenya
2010, and older age was associated with a lower prevalence of
anemia in all surveys except in Liberia and Bangladesh (data not
shown). Other than child age, the most consistent factors that
were associated with anemia across surveys were malaria (5 out
of 5 surveys) and ID (12 out of 15 surveys). Current breast-
feeding was associated with a greater prevalence of anemia in 8
of 11 surveys; in Pakistan, breastfeeding was associated with a
lower prevalence of anemia. When child age (as a continuous
variable) was included in the logistic regression model for anemia
and breastfeeding, breastfeeding remained associated with anemia
in Cameroon, Kenya 2007, Mexico 2012, and the Philippines
and in the pooled analyses for moderate-, high-, and very high–
infection groups.
Stunting, underweight, inflammation, low SES, and household
sanitation were also associated with anemia in .50% of the
surveys for which these variables were available, and VAD was
associated with anemia in 5 of 12 surveys (Table 3). An elevated
CRP concentration was associated with anemia in 8 of 14 sur-
veys (0 of 5 surveys in low- and moderate-infection groups and
8 of 9 surveys in high- and very high–infection groups), whereas
elevated AGP was associated with anemia in 10 of 11 surveys
(data not shown). Any inflammation was associated with anemia
in 9 of 10 surveys in the high- and very high–infection groups
but in only 1 survey (Nicaragua) in the moderate- and low-
infection groups (n = 6 surveys). Of the covariates examined,
male sex (2 of 16 surveys) and the household water source (3 of
11 surveys) were associated with anemia in the smallest pro-
portion of surveys.
The proportion of PSCwith both anemia and any inflammation
was 0.2%, 2.5%, 31.3%, and 47.9% in the countries with low,
moderate, high, and very high infection burdens, respectively;
in anemic children, the proportion with any inflammation was
TABLE 2
Nutritional status, and prevalence of inflammation and malaria in preschool children by country and category of infection burden: the BRINDA project1
Iron deficiency, %
Vitamin A
deficiency, % Inflammation, % Malaria, % Stunted, % Wasted, %
Country
Bangladesh 13.1 (10.5, 15.7) 8.2 (6.3, 10.2) 35.7 (32.2, 39.3) NA 19.6 (15.8, 23.4) 17.8 (14.9, 20.7)
Cameroon 24.5 (20.8, 28.2) 13.7 (10.9, 16.5) 48.3 (43.0, 53.5) 25.8 (20.0, 31.5) 32.4 (28.0, 36.8) 3.8 (2.4, 5.2)
Colombia 11.1 (9.7, 12.4) 21.1 (19.3, 23.0) 18.8 (17.1, 20.5) NA 14.0 (12.4, 15.5) 0.7 (0.3, 1.0)
Coˆte d’Ivoire 17.9 (14.9, 20.9) 11.3 (9.2, 13.4) 67.5 (63.7, 71.3) 27.3 (22.4, 32.2) 39.2 (34.3, 44.0) 13.8 (9.1, 18.5)
Georgia 0.3 (0.03, 0.5) NA 24.7 (21.9, 27.6) NA 11.9 (9.0, 14.9) 0.6 (0.2, 0.9)
Kenya 2007 59.1 (54.9, 63.3) 9.3 (6.8, 11.8) 65.5 (61.3, 69.7) 19.9 (16.1, 23.7) 25.3 (22.6, 28.1) 4.4 (2.6, 6.2)
Kenya 2010 39.3 (35.6, 42.9) 13.0 (10.5, 15.6) 61.8 (57.1, 66.5) 32.5 (28.4, 36.6) 26.1 (23.0, 29.2) 3.3 (1.8, 4.9)
Laos 23.0 (19.1, 26.9) NA 43.9 (36.4, 51.4) NA 50.8 (45.2, 56.4) 8.0 (4.7, 11.4)
Liberia 33.7 (30.1, 37.2) 12.1 (9.9, 14.4) 59.1 (55.6, 62.7) 29.4 (26.2, 32.6) 35.1 (31.9, 38.2) 9.2 (7.4, 10.9)
Mexico 2006 24.8 (21.6, 28.1) NA 11.2 (9.0, 13.4) NA 21.0 (17.1, 24.8) 1.3 (0.2, 2.3)
Mexico 2012 17.4 (15.2, 19.7) 14.6 (12.0, 17.1) 12.1 (9.6, 14.7) NA 15.2 (13.0, 17.3) 0.8 (0.4, 1.3)
Nicaragua 47.9 (41.7, 54.2) 1.1 (0.5, 1.7) 24.0 (20.5, 27.5) NA 18.9 (14.8, 23.1) 0.3 (0.04, 0.6)
Pakistan 51.6 (50.0, 53.1) 54.4 (52.2, 56.6) 35.5 (34.1, 37.0) NA 44.3 (42.8, 45.7) 15.3 (14.4, 16.3)
Papua New Guinea NA 13.7 (11.1, 16.4) 57.0 (52.5, 61.5) NA 44.2 (38.9, 49.4) 4.3 (2.5, 6.1)
Philippines 35.8 (32.3, 39.2) 1.6 (0.4, 0.9) 26.0 (22.4, 29.5) NA 26.4 (22.8, 30.1) 5.2 (3.6, 6.7)
United States 11.7 (8.9, 14.4) NA 6.0 (4.5, 7.5) NA 3.6 (1.9, 5.3) 0.5 (0, 1.1)
Infection burden
Low 13.1 (10.2, 16.0) NA 6.2 (4.8, 7.6) NA 3.7 (2.1, 5.3) 0.5 (0, 1.0)
Moderate 23.3 (21.5, 25.1) 10.3 (9.1, 11.5) 12.9 (11.7, 14.1) NA 17.6 (15.7, 19.5) 1.0 (0.5, 1.5)
High 43.8 (42.3, 45.3) 32.3 (30.8, 33.8) 33.3 (31.9, 34.7) NA 37.6 (36.2, 39.0) 11.9 (11.1, 12.6)
Very high 54.4 (52.5, 56.4) 5.8 (5.0, 6.6) 63.0 (60.8, 65.2) 26.7 (24.5, 28.9) 30.2 (28.3, 32.1) 6.7 (5.3, 8.1)
1 All values are proportions (95% CIs). Iron deficiency was defined as an inflammation-adjusted ferritin concentration ,12 mg/L. Vitamin A deficiency
was defined as an inflammation-adjusted retinol concentration (Colombia, Mexico 2012, and Nicaragua) or a retinol-binding protein concentration (all other
surveys),0.70 mmol/L. Iron and vitamin A values were adjusted by regression with the use of reference CRP and AGP concentrations that were equivalent to
the first decile of a reference population. Values were adjusted for CRP and AGP when both were available or for only CRP or AGP if only one was available.
Inflammation was defined as a CRP concentration.5 mg/L or AGP concentration.1 g/L [only AGP data were available in Nicaragua and Pakistan, and only
CRP data were available in Colombia, Georgia, Mexico (2006 and 2012), and the United States]. Stunted and wasted were defined as z scores ,22 SDs for
height- or length-for-age and weight-for-height or -length, respectively, according to WHO growth standards. Countries were grouped as follows—low infection
burden: Georgia and the United States; moderate infection burden: Colombia, Mexico (2006 and 2012), and Nicaragua; high infection burden: Bangladesh,
Laos, Pakistan, Papua New Guinea, and the Philippines; and very high infection burden: Cameroon, Coˆte d’Ivoire, Kenya (2007 and 2010), and Liberia. AGP,
a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; NA, not available.
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9.1%, 13.7%, 37.4%, and 70.3%, respectively (Supplemental
Figure 2).
Fewer predictors were identified for severe anemia (Tables 5
and 6); the most consistent predictors were malaria (4 of 5
surveys), poor sanitation (3 of 4 surveys), and underweight
(6 of 9 surveys). Inflammation was associated with severe
anemia in all 5 African countries but in none of the Asian
countries. Male sex and recent diarrhea were not associated
with severe anemia.
Anemia associated with ID
The relative prevalences of anemia, ID, and IDA (defined as
having both anemia and ID) varied widely by infection group
and among countries within infection groups (Supplemental
Figures 3 and 4). The proportion of anemic PSC who had
unadjusted ferritin concentrations ,12 mg/L ranged from
,1% in Georgia to 57% in the United States with an (un-
weighted) mean of 28% for all surveys. After ferritin con-
centrations were adjusted for inflammation, the proportion of
anemic PSC with ID (regression-adjusted ferritin concentration
,12 mg/L) increased in all surveys (unweighted mean of 43%
for all surveys). In pooled analyses, the proportion of anemic
PSC with ID, which was defined with the use of unadjusted
ferritin concentrations, was 50%, 23%, 48%, and 26% in the
low-, moderate-, high-, and very high–infection burden groups,
respectively (Supplemental Figure 5); the corresponding values
were 50%, 30%, 55%, and 58%, respectively, with the use of
inflammation-adjusted ferritin concentrations (Figure 1). The
large change in the proportion of anemic individuals with ID in
the very high–infection group was explained by the number of
anemic individuals with inflammation who were newly clas-
sified as iron deficient after adjustment for inflammation
(w17% of the total population) compared with a moderate
increase in ID cases in nonanemic individuals (Supplemental
Figures 6–9).
The examination of the prevalence of anemia in individuals
with and without ID provided a somewhat different picture,
whereby the absolute difference in the prevalence of anemia in
individuals with and without ID in the very high–infection
group was 16 pp when unadjusted ferritin was used and only
9 pp when adjusted ferritin was used (Figure 2). The differ-
ence in anemia prevalence in individuals with and without
ID (using adjusted ferritin) was 25, 7, and 8 pp in the high-,
moderate-, and low-infection groups, respectively, and was
minimally affected by the adjustment to ferritin (#2.3 pp).
Multivariable models of predictors of anemia
There was significant heterogeneity (P , 0.001) in relations
between anemia and age, breastfeeding status, and inflammation
between infection groups. Within infection groups, there was
significant heterogeneity in relations between anemia and indi-
vidual covariates by survey for a number of covariate–infection-
group combinations although, in general, the relations were in a
similar direction across surveys as suggested in Tables 2–6.
In exploratorymultivariable models, child age, ID (except for
severe anemia in the very high–infection group), and stunting
(except for anemia in the low-infection group) independently
predicted anemia in infection subgroups (Table 7). In addition, T
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inflammation was associated with anemia in the high- and very
high–infection groups but not in the low- and moderate-infection
groups. In the very high–infection group only, male sex was in-
dependently positively associated with anemia, and malaria was
associated with both anemia and severe anemia. Other indepen-
dent predictors of anemia and severe anemia differed by the set-
ting, and included wasting, household sanitation and water, VAD,
and rural location. Several interactions with age remained signif-
icant in final multivariable models although the specific interac-
tions that were detected differed by the infection group; these
interactions included those between age and inflammation, sanitation,
ID, and wasting.
DISCUSSION
In this analysis of data from nearly 30,000 PSC from 16 cross-
sectional surveys, we identified nutritional and nonnutritional
factors that are associated with anemia and severe anemia in
young children. Consistent with conceptual models of anemia (8),
there were clear associations with ID, stunting, underweight, in-
flammation, unimproved household sanitation, and low SES. Some
associations, such as ID, were consistent across all surveys. Other
factors, such as inflammation, were associated with anemia pri-
marily in settings with a greater burden of infectious disease.
These results are useful for identifying geographic areas
where, and population subgroups in whom, anemia and severe
anemia are likely to be prevalent. Findings from this work highlight
the context-dependent nature of anemia both in terms of the total
burden and the individual characteristics and environmental con-
ditions that are associated with anemia. Specifically, in countries
with a high burden of infectious disease and infectious disease risk
factors, anemia prevalence was high, and anemia was associated
with variables that are related to infection, sanitation, and inflam-
mation in addition to iron status. In contrast, in settings with lower
infectious disease burden, the total prevalence of anemia was lower,
and ID appeared to be a more important predictor of anemia. These
results are consistent with a recent analysis of NHANES data from
the United States where an estimated 38% of anemia in children
aged 12–59 mo was attributable to ID (35).
The positive relation between breastfeeding and anemia was no
longer significant after controlling for child age in 5 of 9 surveys for
which the bivariate association was significant. This association
between anemia and breastfeeding in the remaining 4 countries
likely reflected confounding by other individual or household char-
acteristics (e.g., children in poor households may be more likely to
be anemic and more likely to receive continued breastfeeding than
are children in wealthier households), but an in-depth exploration
of these pathways was beyond the scope of this paper. The asso-
ciationmay also be explained by inadequate complementary feeding
practices in this sample of children.6 mo of age, but the dietary
intake data needed to confirm this explanation were limited.
Hemoglobin concentrations are commonly measured in large
surveys, such as in Demographic and Health Surveys, which
enable the estimation of the global burden of anemia and trends
(1). However, indicators of potential causes of anemia (such as
iron-status biomarkers, infections, and hemoglobinopathies) are
not routinely measured in surveys to assess anemia prevalence;
this lack of data limits efforts to understand the etiology of anemia
and to develop appropriate interventions. A large modeling anal-
ysis, which used data and methods from the Global Burden of
Diseases, Injuries, and Risk Factors 2010 study, applied estimated
shifts in hemoglobin concentrations (derived from literature re-
views and meta-analyses) from interventions, such as iron sup-
plementation, to estimate the cause-specific attribution for anemia
(8). The authors estimated that ID was the primary cause of anemia
globally (with an average contribution close to 50%) followed by
hookworm infection, genetic hemoglobin disorders, and malaria,
although therewas some heterogeneity in the relative importance of
causes across regions (8). In a recent WHO report, the estimated
proportion of “anemia that is amenable to iron supplementation”
in children 6–59 mo of age in 2011, which was also estimated
by applying shifts in the mean hemoglobin concentration to
population hemoglobin distributions, was 32% in the Africa re-
gion, 41% in South-East Asia, and 56% in the Americas (36). Our
analyses, which used individual-level data, are consistent with the
emphasis on both nutritional and nonnutritional causes and the
heterogeneity of anemia etiology by region.
The observed proportion of anemic individuals with concomitant
ID increased after the adjustment of ferritin concentrations for
FIGURE 1 Venn diagrams illustrating the prevalence of iron deficiency,
anemia, iron deficiency and anemia, and proportion of anemic individuals
with iron deficiency in preschool children by category of infection burden:
Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia
(BRINDA) project. Values are proportions. Iron deficiency was defined as an
inflammation-adjusted ferritin concentration ,12 mg/L. Ferritin values were
adjusted by regression with the use of reference CRP and AGP concentrations
that were equivalent to the first decile of a reference population. Values were
adjusted for CRP and AGP when both were available or for only CRP or AGP
if only one was available. Any inflammation defined as was defined as a CRP
concentration .5 mg/L or AGP concentration .1 g/L. Only AGP data were
available in Nicaragua and Pakistan. Only CRP data were available in Colom-
bia, Georgia, Mexico (2006 and 2012), and the United States. Anemia was
defined as a hemoglobin concentration ,110 g/L. Countries were grouped as
follows—low infection burden: Georgia and the United States; moderate infec-
tion burden: Colombia, Mexico (2006 and 2012), and Nicaragua; high infection
burden: Bangladesh, Laos, Pakistan, Papua New Guinea, and the Philippines;
and very high infection burden: Cameroon, Coˆte d’Ivoire, Kenya (2007 and
2010), and Liberia. AGP, a-1-acid glycoprotein; CRP, C-reactive protein.
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inflammation, thereby suggesting that a failure to measure and
adjust mathematically for indicators of inflammation may un-
derestimate the underlying prevalence of ID and IDA (32). With
the use of the inflammation-adjusted ferritin values, the proportion
of anemic PSC who also had ID was w50% for the low-, high-,
and very high–infection groups. However, the corresponding value
in the moderate-infection group was only 30%; note that all sur-
veys in this group only measured a single acute-phase protein
(either CRP or AGP), and the ferritin adjustment had a relatively
smaller impact on the prevalence of ID in these surveys (32).
Thus, it is possible that the use of 2 acute-phase proteins to adjust
ferritin concentrations would increase the estimated prevalence
of ID and the proportion of anemia that is associated with ID in
these countries.
We report the prevalence of IDA as it is conventionally defined
(concomitant ID plus anemia) as well as the proportion of anemic
individuals with ID. However, these numbers are not equivalent
to the proportion of anemia that will be resolved by the provision
of iron because a child with ID may also have anemia that is
caused by another factor. In the BRINDA data set, in the 54% of
children with ID in the group with very high infection burden
(countries in sub-Saharan Africa), the prevalence of anemia was
72%, but in PSC without ID, the prevalence of anemia was 63%.
In this example, theoretically eliminating ID would reduce the
prevalence of anemia by a maximum of 9 pp (i.e., 72–63 pp). In
the group with high infection burden (countries in Asia), the
prevalence of anemia was 70.5% in PSC with ID and 45.5% in
those without ID, which suggested that, hypothetically, there
may be a greater impact of iron interventions in these settings.
However, simply examining the proportion of anemic children
with ID (58% and 55% for countries with very high and high
infection burdens, respectively) obscures this distinction.
This suggestion is supported by the results of a recent trial in a
population of children age 12–36 mo in Coˆte d’Ivoire with high
IDA prevalence at baseline (24–38% IDA by group, defined as
ID plus anemia) (37). In this trial, the provision of iron-fortified
complementary foods (CFs) for 9 mo reduced the prevalences of
ID and IDA in the CF groups compared with those in the control
group at 9 mo postintervention, but reductions in total anemia
prevalence were less pronounced: at 9 mo postintervention,
the prevalence of IDAwas 18.7%, 1.2%, and 3.4%, and total anemia
prevalence was 71.1%, 70.4%, and 65.5% in the control, CF fer-
rous fumarate, and CF ferric pyrophosphate groups, respectively.
These results suggest that defining IDA simply as having ID plus
anemia, while indicative of a potential benefit of iron interven-
tions, may overestimate the reduction in total anemia prevalence
that would be expected after the provision of iron (even when
issues of dosage, duration, and compliance are disregarded). We
did not present population-attributable risk calculations because
they are considered inappropriate for cross-sectional data from
which causality cannot be inferred; however, because of the known
biological relations between ID and anemia, future efforts to ex-
plore the application of population-attributable risk estimates may
be useful for studies that aim to predict the proportion of anemia
that could be resolved through iron-intervention programs.
A second caveat with regard to programmatic implications of
delivering iron is that uncertainties remain about how best to
manage iron-intervention programs in the context of a high
burden of infectious disease. The administration of iron during
inflammation may be ineffective if hepcidin is elevated (38) and
may also be harmful in the case of certain infections (12, 13). The
regression adjustment for ferritin used in this article and described
by Namaste et al. (7) uses lower reference values for markers of
inflammation in comparison to previous methods. Thus, presum-
ably, this method identifies a greater proportion of cases of
underlying iron deficiency which may be masked by low-level
inflammation. Thus, this method may be useful to better estimate
the underlying prevalence of ID and to monitor trends and re-
sponses to intervention, although longitudinal studies are needed
to confirm the validity of this approach. However, decisions about
when, how, and to whom to administer iron should take into
account potential interactions with infections.
A major strength of this analysis is the availability of
individual-level data on potential risk factors for anemia from 16
surveys from diverse geographic regions yielding large pooled
sample sizes for groups with varying burden of infections. How-
ever, missing information on other potential causes of anemia
(e.g., genetic factors, helminths and other infections, and B vitamin
FIGURE 2 Prevalence (95% CI) of anemia in children with and without iron deficiency by category of infectious disease burden and adjustment of an
iron-status indicator (ferritin) for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Ferritin
values were adjusted by regression with the use of reference CRP and AGP concentrations that were equivalent to the first decile of a reference population.
Values were adjusted for CRP and AGP when both were available or for only CRP or AGP if only one was available. Countries were grouped as follows—low
infection burden: Georgia and the United States; moderate infection burden: Colombia, Mexico (2006 and 2012), and Nicaragua; high infection burden:
Bangladesh, Laos, Pakistan, Papua New Guinea, and the Philippines; and very high infection burden: Cameroon, Coˆte d’Ivoire, Kenya (2007 and 2010), and
Liberia. AGP, a-1-acid glycoprotein; CRP, C-reactive protein; Hb, hemoglobin.
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ANEMIA IN PRESCHOOL CHILDREN 413S
status) still limits the extent to which we could examine all possible
contributors to anemia. In addition, several methodologic factors
affect the measurement of anemia. The use of capillary blood
samples (as in themajority of surveys included here) can potentially
underestimate hemoglobin concentrations if excessive pressure is
applied to the finger during blood collection. Differences in lab-
oratory methods could also introduce error into the results although
this potential source of variation did not appear to affect our ability
to detect patterns of associationwith anemia across surveys. Finally,
an important limitation of the use of cross-sectional data is the in-
ability tomake inferences about the etiology of anemia. Nevertheless,
the bivariate associations are useful for identifying individuals or
population subgroups who are likely to be anemic.
The identification of independent relations between anemia and
biomarkers of infection, inflammation, and micronutrient status is
complicated by the biological interactions between infection and
nutritional status. With current methods, an individual’s underlying
iron or vitamin A status (stores) cannot be known with certainty
when inflammation is present. We have addressed this issue, to the
extent possible, by using what we believe are novel methods to adjust
markers of ID and VAD for the presence of systemic inflammation
that do not rely on arbitrary cutoffs for CRP and AGP, although
further evidence for the validity of these approaches is needed.
We used a hemoglobin-concentration cutoff of 110 g/L to
define anemia for consistency with WHO guidelines for children
aged 6–59 mo (29). However, there has been some evidence to
suggest that this value could overestimate the prevalence of
anemia, particularly for younger children, if the statistical cutoff
of a mean of –2 SDs (although not necessarily a gold standard)
is applied to estimate the threshold for anemia. NHANES II data
were used to support the WHO 2001 anemia cutoffs, but in those
data, the concentration that was equivalent to the mean of
–2 SDs of hemoglobin in non-ID children was 105 g/L for chil-
dren aged 0.5–0.99 y, and 107 g/L for children aged 1.0–4.99 y
(29, 39). In addition, concentration cutoffs of 105 g/L at 4–6 mo
of age and 100 g/L at 9 mo of age were suggested on the basis of
data from iron-replete infants in a supplementation study (40).
We observed positive relations between age and hemoglobin in
all but 3 surveys, and the associations between age and anemia
were independent of other risk factors for anemia as have been
observed elsewhere (39, 41). By controlling for age in the
multivariable models, we were able to examine the independent
associations of other characteristics with anemia.
In exploratory multipredictor models, we observed interac-
tions with age and selected covariates. In general, these inter-
actions suggest that ID may be a more important predictor of
anemia in younger children and that inflammation and related
variables (such as household sanitation) are more important in
older children (all age #59 mo in this analysis), thereby implying
that anemia-control efforts may be strengthened by age-specific
actions. These relations should be further examined with the use of
appropriate analytic methods such as a path analysis.
Despite efforts to implement programs to address child anemia,
there has been limited progress toward this objective globally and
particularly in sub-Saharan Africa. In general, our results suggest
that, in settings with low andmoderate burdens of infectious disease,
nutritional factors such as ID are important contributors to anemia.
In contrast, in settings with a high burden of infectious disease, the
contributors to anemia are more diverse, and both nutrition and
infectious disease control are important factors to address.
In conclusion, the heterogeneity in results by country indicates
that data collection with a focus on potential risk factors for
anemia should be a priority to understand the likely etiology of
anemia in a setting before designing programs. Indeed, risk
factors for anemia may also differ within countries where there is
diversity in the geography, dietary patterns, and burden of in-
fectious disease. In addition, data on nonmodifiable risk factors
for anemia (such as hemoglobinopathies) are needed to assess the
extent to which anemia-control programs can be expected to have
an impact. Concerns have been raised about possible risks of
providing additional iron to individuals with adequate iron status
and/or to individuals who are living in settings with high burdens
of malaria and other infectious diseases (42). Until a rapid, in-
expensive diagnosis of ID and inflammation in individuals is
feasible, estimates of the prevalence of ID and IDA in a country or
geographic region can provide guidance to programs. Where
feasible, iron-status indicators, such as ferritin, should be mea-
sured in nutrition surveys, and indicators of inflammation, such as
CRP and AGP, should be measured concurrently, to permit the
interpretation of ferritin concentrations. Finally, the burden and
distribution of infectious disease should be considered in de-
cisions regarding when, where, and to whom to provide iron.
Interactions with age should be considered for relevance to policy
decisions including program targeting.
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